Skip to main content

Published locations for CARMELINA confirms linagliptin’s renal, CV safety, but it’s still third-line for type 2 diabetes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CARMELINA confirms linagliptin’s renal, CV safety, but it’s still third-line for type 2 diabetes

User login

  • Reset your password
  • /content/carmelina-confirms-linagliptins-renal-cv-safety-its-still-third-line-type-2-diabetes
  • /clinicianreviews/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still
  • /familypracticenews/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still
  • /internalmedicinenews/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its
  • /clinicalendocrinologynews/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety
  • /jcomjournal/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still-third
  • /ecardiologynews/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still
  • /cardiology/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still-third
  • /endocrinology/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still
  • /internalmedicine/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still
  • /familymedicine/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its-still
  • /type-2-diabetes-icymi/article/204753/diabetes/carmelina-confirms-linagliptins-renal-cv-safety-its